The pilot will use the fast-acting drug Fibrinogen, which has shown promising results in a Welsh study for its clinical benefits ...
A MATERNITY unit has received additional funding to launch a two-year pilot to help revolutionise care for birthing mothers, ...
Department of Chemistry, University of Michigan, 930 North University Avenue Ann Arbor, Michigan 48103, United States ...
Preeclampsia, a pregnancy-specific condition marked by hypertension and proteinuria, has been identified as a risk factor for postpartum depression ...
fncls.ssp?fn=show_t_gif&application_id=2063989&application_name=news&site_id=newmediawire~~~ce31e09e-58c0-4982-8e07-f69a10de079e ...
Spanish firm Grifols (MCE: GRF) has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US Food and Drug Administration (FDA). Grifols claims that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results